The aim of this standard operating procedure is to provide testing, as required by a clinically led risk-based approach, to inpatients, using polymerase chain reaction (PCR) tests and lateral flow devices (LFDs) from 1 April 2022. This will reduce the risk of nosocomial transmission and allow for action to be taken to isolate COVID-19 positive inpatients.